Cite
HARVARD Citation
Wang, L. et al. (2020). Cost‐effectiveness analysis of trastuzumab emtansine (T‐DM1) in treating HER‐2 positive advanced breast cancer in Taiwan. Breast journal. 26 (10), pp. 2099-2102. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wang, L. et al. (2020). Cost‐effectiveness analysis of trastuzumab emtansine (T‐DM1) in treating HER‐2 positive advanced breast cancer in Taiwan. Breast journal. 26 (10), pp. 2099-2102. [Online].